SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-039807
Filing Date
2019-02-14
Accepted
2019-02-14 11:47:33
Documents
3
Group Members
FORBION I MANAGEMENT B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d704304dsc13da.htm SC 13D/A 65655
2 EX-99.1 d704304dex991.htm EX-99.1 3889
3 EX-99.2 d704304dex992.htm EX-99.2 37294
  Complete submission text file 0001193125-19-039807.txt   108318
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Subject) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88006 | Film No.: 19603103
SIC: 2834 Pharmaceutical Preparations

Mailing Address GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411 DC 31 35 6993000
ForArgos B.V. (Filed by) CIK: 0001669166 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A